Journal of Clinical Oncology

<i>NOTCH1</i> : A Potential New Biomarker in the Era of Immunotherapy?

E Ergin Aydemir (Ergin Aydemir, MD, Department of Medical Oncology, Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey; Nejat Emre Öksüz, MD, Department of Medical Oncology, Ankara University, Ankara, Turkey; and Kadriye Bir Yücel, MD, Department of Medical Oncology, Etlik City Hospital, Ankara, Turkey) N Nejat Emre Oksuz K Kadriye Bir Yucel (Etlik City Hospital, Department of Medical Oncology, Ankara, Turkey)
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 43, Issue 33
Published November 20, 2025
Pages 3627-3627
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (3)

E

Ergin Aydemir

Ergin Aydemir, MD, Department of Medical Oncology, Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey; Nejat Emre Öksüz, MD, Department of Medical Oncology, Ankara University, Ankara, Turkey; and Kadriye Bir Yücel, MD, Department of Medical Oncology, Etlik City Hospital, Ankara, Turkey

N

Nejat Emre Oksuz

K

Kadriye Bir Yucel

Etlik City Hospital, Department of Medical Oncology, Ankara, Turkey

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001